A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Inclusion Criteria: 1. Willing and able to give written informed consent 2. Between the ages of 18 and 65 years (inclusive) 3. Fulfilled at least 4 ACR classification criteria 4. SLE patients with moderate, active disease 5. Subjects on stable dose of SLE medications for at least 4 weeks before randomization. 6. Women of child-bearing potential must practice a medically acceptable method of contraception.. 7. Must understand the requirements of the study and agree to comply with the study protocol. Exclusion Criteria: 1. Any condition which the investigator feels may interfere with participation in the study. 2. Subjects having a history of chronic infection 3. Subjects with a history of immunodeficiency syndrome or malignancy, 4. Subjects who received any investigational medication (including DHEA) within 3 months prior to randomization, 5. Subjects treated with any cytotoxic agents in the 3 months prior to randomization.